Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 11

Results For "biological"

239 News Found

IIT Kanpur and University at Buffalo to enrich research in Biomedicine & Bioengineering
News | March 25, 2023

IIT Kanpur and University at Buffalo to enrich research in Biomedicine & Bioengineering

The agreement will facilitate the establishment of the IITK-UB Joint Center of Excellence in Biomedicine and Bioengineering


IIT Kanpur and Reliance Life Sciences join forces to revolutionize gene therapy for hereditary eye diseases
News | March 11, 2023

IIT Kanpur and Reliance Life Sciences join forces to revolutionize gene therapy for hereditary eye diseases

IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases


Artificial intelligence facilitates low-cost drug repurposing, says GlobalData
Digitisation | February 11, 2023

Artificial intelligence facilitates low-cost drug repurposing, says GlobalData

The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.


Thermo Fisher launches big foot cell sorter in India
News | January 25, 2023

Thermo Fisher launches big foot cell sorter in India

Cell sorting technology supports researchers advancing new therapies


Vidita Vaidya awarded Infosys Prize 2022 in Life Sciences
News | January 10, 2023

Vidita Vaidya awarded Infosys Prize 2022 in Life Sciences

In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual


IIT Kanpur and Apollo Hospitals join hands for research collaboration
News | January 04, 2023

IIT Kanpur and Apollo Hospitals join hands for research collaboration

The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology


Polysciences announces new bioprocessing brand ‘Kyfora Bio’
News | January 03, 2023

Polysciences announces new bioprocessing brand ‘Kyfora Bio’

Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.


MoU signed for commercial production of indigenously developed vaccine ‘Lumpi-ProVac’
Policy | January 02, 2023

MoU signed for commercial production of indigenously developed vaccine ‘Lumpi-ProVac’

Lumpi-ProVacind is used for the prophylactic immunization of animals against Lumpy Skin Disease, which illicit protection for about one year


ICON selected by BARDA to conduct anthrax vaccine clinical trial
Diagnostic Center | October 09, 2022

ICON selected by BARDA to conduct anthrax vaccine clinical trial

This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.